Prediction of furan pharmacokinetics from hepatocyte studies: Comparison of bioactivation and hepatic dosimetry in rats, mice, and humans'

Toxicology and Applied Pharmacology

Volumn 140, Issue 1, 1996, Pages 124-130

  Kedderis, Gregory L ^a   Held, Sara D ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; FURAN;

ANIMAL CELL; ARTICLE; BIOAVAILABILITY; BIOTRANSFORMATION; BLOOD FLOW; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INDUCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; RAT; SPECIES DIFFERENCE; TOXICOKINETICS;

ANIMALIA; RODENTIA;

EID: 0030246901     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0205     Document Type: Article

References (38)

1. Arias, I. M., Popper, H., Schachter, D., and Shafritz, D. A. (1982). The Liver: Biology and Pathobiology. Raven Press, New York.
2. Arms, A. D., and Travis, C. C. (1988). Reference Physiological Parameters in Pharmacokinetic Modeling. US EPA/600/6-88/004, Final Report, NTIS, PB88-196019.
3. Bayliss, M. K., Bell, J. A., Jenner, W. N., and Wilson, K. (1990). Prediction of intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes. Biochem. Soc. Trans. 18, 1198-1199.
4. Billings, R. E., McMahon, R. E., Ashmore, J., and Wagle, S. R. (1977). The metabolism of drugs in isolated rat hepatocytes: A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions. Drug Metab. Dispos. 5, 518-526.
5. 14C]furan in the male F-344 rat. J. Toxicol. Environ. Health 34, 245-257.
6. Carfagna, M. A., Held, S. D., and Kedderis, G. L. (1993). Furan-induced cytolethality in isolated rat hepatocytes: Correspondence with in vivo dosimetry. Toxicol. Appl. Pharmacol. 123, 265-273.
7. Chen, L.-J., Hecht, S. S., and Peterson, L. A. (1995). Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. Chem. Res. Toxicol. 8, 903-906.
8. Chenery, R. J., Ayrton, A., Oldham, H. G., Standring, P., Norman, S. J., Seddon, T., and Kirby, R. (1987). Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig, and man. Drug Metab. Dispos. 15, 312-317.
9. Dedrick, R. L., and Forrester, D. D. (1973). Blood flow limitations in interpreting Michaelis constants for ethanol oxidation in vivo. Biochem. Pharmacol. 22, 1133-1140.
10. Elcombe, C. R. (1985). Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: A biochemical human hazard assessment. Arch. Toxicol. (Suppl. 8), 6-17.
11. Gargas, M. L., Andersen, M. E., and Clewell, H. J., III (1986a). A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 86, 341-352.
12. Gargas, M. L., Clewell, H. J., III, and Andersen, M. E. (1986b). Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathways. Toxicol. Appl. Pharmacol. 82, 211-223.
13. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98, 87-99.
14. Green, C. E., LeValley, S. E., and Tyson, C. A. (1986). Comparison of amphetamine metabolism using isolated hepatocytes from five species including human. J. Pharmacol. Exp. Ther. 237, 931-936.
15. Guengerich, F. P., Kim, D.-H., and Iwasaki, M. (1991). Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168-179.
16. Houston, J. B. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47, 1469-1479.
17. Kedderis, G. L. (1996). Hepatic blood flow limitation of the bioactivation of hazardous chemical air pollutants. Fundam. Appl. Toxicol. 30, 34-35.
18. Kedderis, G. L., Argenbright, L. S., and Miwa, G. T. (1988). Studies with nitrogen-containing steroids and freshly isolated rat hepatocytes: Role of cytochrome P450 in detoxication. Toxicol. Appl. Pharmacol. 93, 403-412.
19. Kedderis, G. L., Carfagna, M. A., Held, S. D., Batra, R., Murphy, J. E., and Gargas, M. L. (1993). Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicol. Appl. Pharmacol. 123, 274-282.
20. Kukan, M., Bezek, S., Pool, W. F., and Woolf, T. F. (1994). Metabolic disposition of tacrine in primary suspensions of rat hepatocytes and in single-pass perfused liver: In vitro/in vivo comparisons. Xenobiotica 24, 1107-1117.
21. Kukongviriyapan, V., and Stacey, N. H. (1988). Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 247, 685-689.
22. Lewis, R. J., Sr. (1992). Furan. Sax's Dangerous Properties of Industrial Materials, 8th ed., Vol. II, pp. 1763-1764. Van Nostrand Reinhold, New York.
23. Lin, J. H., Sugiyama, Y., Awazu, S., and Hanano, M. (1982). Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data. J. Pharmacokin. Biopharm. 10, 649-661.
24. Maga, J. A. (1979). Furans in foods. Crit. Rev. Food Sci. Nutrit. 11, 355-366.
25. Masuda, Y., Nakayama, N., Yamaguchi, A., and Murohashi, M. (1984). The effects of diethyldithiocarbamate and carbon disulfide on acute nephrotoxicity induced by furan, bromobenzene and cephaloridine in mice. Jpn. J. Pharmacol. 34, 221-229.
26. Mordenti, J. (1986). Man versus beast: Pharmacokinetic scaling in mammals. J. Pharm. Sci. 75, 1028-1040.
27. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E. (1986). Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ. Mutagen. (Suppl. 7), 1-119.
28. National Toxicology Program (1993). Toxicology and Carcinogenesis Studies of Furan in F-344/N Rats and B6C3F1 Mice. NTP Technical Report 402, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
29. Northrop, D. B. (1983). Fitting enzyme-kinetic data to V/K. Anal. Biochem. 132, 457-461.
30. Oldham, H. G., Chenery, R. J., Standring, P., Norman, S. J., Garton, A., and Ayrton, A. D. (1986). Drug metabolism kinetic studies in a hepatocyte model. Food Chem. Toxicol. 24, 761-762.
31. Perrot, N., Nalpas, B., Yang, C. S., and Beaune, P. H. (1989). Modulation of cytochrome P450 isozymes in human liver by ethanol and drug intake. Eur. J. Clin. Invest. 19, 549-555.
32. Raucy, J. L., Kraner, J. C., and Lasker, J. M. (1993). Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23, 1-20.
33. Seddon, T., Michelle, I., and Chenery, R. J. (1989). Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog. Biochem. Pharmacol. 38, 1657-1665.
34. Seglen, P. O. (1976). Preparation of isolated rat liver cells. Methods Cell Biol. 13, 29-83.
35. Singh, K., Tripp, S. L., Dunton, A. W., Douglas, F. L., and Rakhit, A. (1991). Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes. Drug Metab. Dispos. 19, 990-996.
36. Strom, S. C., Jirtle, R. L., Jones, R. S., Novicki, D. L., Rosenberg, M. R., Novotny, A., Irons, G., McLain, J. R., and Michalopoulos, G. (1982). Isolation, culture, and transplantation of human hepatocytes. J. Natl. Cancer Inst. 68, 771-778.
37. West, J. B., and Wagner, P. D. (1991). Ventilation-perfusion relationships. In The Lung: Scientific Foundations (R. G. Crystal and J. B. West, Eds.), Vol. 2, pp. 1289-1305. Raven Press, New York.
38. Wilson, D. M., Goldsworthy, T. L., Popp, J. A., and Butterworth, B. E. (1992). Evaluation of genotoxicity, pathological lesions and cell proliferation in livers of rats and mice treated with furan. Environ. Mol. Mutagen. 19, 209-222.